Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)

(-) Description

Title :  HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TACRINE
 
Authors :  F. Nachon, E. Carletti, C. Ronco, M. Trovaslet, Y. Nicolet, L. Jean, P. -
Date :  06 Oct 12  (Deposition) - 29 May 13  (Release) - 09 Apr 14  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.10
Chains :  Asym. Unit :  A
Biol. Unit 1:  A  (1x)
Keywords :  Hydrolase, Nerve Transmission, Inhibitior, Alpha-Beta Hydrolase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  F. Nachon, E. Carletti, C. Ronco, M. Trovaslet, Y. Nicolet, L. Jean, P. Renard
Crystal Structures Of Human Cholinesterases In Complex With Huprine W And Tacrine: Elements Of Specificity For Anti- Alzheimer'S Drugs Targeting Acetyl- And Butyrylcholinesterase.
Biochem. J. V. 453 393 2013
PubMed-ID: 23679855  |  Reference-DOI: 10.1042/BJ20130013

(-) Compounds

Molecule 1 - CHOLINESTERASE
    ChainsA
    EC Number3.1.1.8
    EngineeredYES
    Expression SystemCRICETULUS GRISEUS
    Expression System Cell LineCHO-K1
    Expression System CommonCHINESE HAMSTER
    Expression System PlasmidPGS
    Expression System Taxid10029
    Expression System Vector TypePLASMID
    FragmentCATALYTIC DOMAIN, RESIDUES 29-557
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymBUTYRYLCHOLINESTERASE, ACYLCHOLINE ACYLHYDROLASE, BUTYRYLCHOLINE ESTERASE, CHOLINE ESTERASE II, PSEUDOCHOLINESTERASE

 Structural Features

(-) Chains, Units

  1
Asymmetric Unit A
Biological Unit 1 (1x)A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (9, 25)

Asymmetric Unit (9, 25)
No.NameCountTypeFull Name
1CL2Ligand/IonCHLORIDE ION
2FPK1Ligand/Ion1-FORMYL-L-PROLINE
3FU41Ligand/Ion2,6-ANHYDRO-1-DEOXY-D-GALACTITOL
4FUL2Ligand/IonBETA-L-FUCOSE
5GOL1Ligand/IonGLYCEROL
6NAG8Ligand/IonN-ACETYL-D-GLUCOSAMINE
7SO42Ligand/IonSULFATE ION
8THA1Ligand/IonTACRINE
9UNX7Ligand/IonUNKNOWN ATOM OR ION
Biological Unit 1 (8, 23)
No.NameCountTypeFull Name
1CL-1Ligand/IonCHLORIDE ION
2FPK1Ligand/Ion1-FORMYL-L-PROLINE
3FU41Ligand/Ion2,6-ANHYDRO-1-DEOXY-D-GALACTITOL
4FUL2Ligand/IonBETA-L-FUCOSE
5GOL1Ligand/IonGLYCEROL
6NAG8Ligand/IonN-ACETYL-D-GLUCOSAMINE
7SO42Ligand/IonSULFATE ION
8THA1Ligand/IonTACRINE
9UNX7Ligand/IonUNKNOWN ATOM OR ION

(-) Sites  (14, 14)

Asymmetric Unit (14, 14)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREASN A:188 , LYS A:190 , NAG A:611 , HOH A:2242BINDING SITE FOR RESIDUE FU4 A 612
02AC2SOFTWARETRP A:82 , GLU A:197 , TYR A:332 , TRP A:430 , HIS A:438 , FPK A:710 , HOH A:2056 , HOH A:2093BINDING SITE FOR RESIDUE THA A 701
03AC3SOFTWARELEU A:18 , TYR A:61 , TRP A:98 , ASP A:129 , LYS A:131BINDING SITE FOR RESIDUE GOL A 702
04AC4SOFTWAREGLN A:316 , GLY A:413 , ASN A:414 , ASN A:415 , HOH A:2216BINDING SITE FOR RESIDUE SO4 A 703
05AC5SOFTWARETRP A:231 , ARG A:242 , SER A:287 , VAL A:288 , HOH A:2145 , HOH A:2154 , HOH A:2155BINDING SITE FOR RESIDUE SO4 A 704
06AC6SOFTWARETHR A:488 , THR A:508 , HOH A:2240BINDING SITE FOR RESIDUE CL A 705
07AC7SOFTWARETYR A:420 , HOH A:2271BINDING SITE FOR RESIDUE CL A 706
08AC8SOFTWAREGLY A:116 , GLY A:117 , SER A:198 , ALA A:199 , LEU A:286 , HIS A:438 , THA A:701 , HOH A:2092BINDING SITE FOR RESIDUE FPK A 710
09AC9SOFTWAREASN A:57 , HOH A:2278BINDING SITE FOR MONO-SACCHARIDE NAG A 601 BOUND TO ASN A 57
10BC1SOFTWAREASN A:106 , ASN A:188 , LYS A:190 , FU4 A:612BINDING SITE FOR MONO-SACCHARIDE NAG A 611 BOUND TO ASN A 106
11BC2SOFTWARETYR A:237 , ASN A:241 , ASN A:245 , LYS A:248 , LEU A:249 , PHE A:278 , PRO A:281 , HOH A:2148BINDING SITE FOR POLY-SACCHARIDE RESIDUES NAG A 621 THROUGH NAG A 623 BOUND TO ASN A 241
12BC3SOFTWAREASN A:256BINDING SITE FOR MONO-SACCHARIDE NAG A 631 BOUND TO ASN A 256
13BC4SOFTWARESER A:338 , ASN A:341 , ASN A:342BINDING SITE FOR POLY-SACCHARIDE RESIDUES NAG A 641 THROUGH NAG A 643 BOUND TO ASN A 341
14BC5SOFTWAREARG A:465 , ASN A:485 , HOH A:2279BINDING SITE FOR MONO-SACCHARIDE NAG A 651 BOUND TO ASN A 485

(-) SS Bonds  (3, 3)

Asymmetric Unit
No.Residues
1A:65 -A:92
2A:252 -A:263
3A:400 -A:519

(-) Cis Peptide Bonds  (1, 1)

Asymmetric Unit
No.Residues
1Ala A:101 -Pro A:102

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (42, 42)

Asymmetric Unit (42, 42)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_072094K40RCHLE_HUMANPolymorphism116047990AK12R
02UniProtVAR_040012T52MCHLE_HUMANDisease (BChE deficiency)56309853AT24M
03UniProtVAR_040013F56ICHLE_HUMANDisease (BChE deficiency)531738678AF28I
04UniProtVAR_040014Y61CCHLE_HUMANDisease (BChE deficiency)116097205AY33C
05UniProtVAR_072730A62VCHLE_HUMANDisease (BChE deficiency)  ---AA34V
06UniProtVAR_040015P65SCHLE_HUMANDisease (BChE deficiency)148170012AP37S
07UniProtVAR_002360D98GCHLE_HUMANDisease (BChE deficiency)1799807AD70G
08UniProtVAR_040016D98HCHLE_HUMANDisease (BChE deficiency)  ---AD70H
09UniProtVAR_072095G103RCHLE_HUMANDisease (BChE deficiency)  ---AG75R
10UniProtVAR_072096E118DCHLE_HUMANDisease (BChE deficiency)  ---AE90D
11UniProtVAR_040017N124YCHLE_HUMANDisease (BChE deficiency)  ---AN96Y
12UniProtVAR_072097I127MCHLE_HUMANPolymorphism755600722AI99M
13UniProtVAR_040018P128SCHLE_HUMANDisease (BChE deficiency)3732880AP100S
14UniProtVAR_040019G143DCHLE_HUMANDisease (BChE deficiency)201820739AG115D
15UniProtVAR_040020L153FCHLE_HUMANDisease (BChE deficiency)747598704AL125F
16UniProtVAR_040021Y156CCHLE_HUMANDisease (BChE deficiency)121918558AY128C
17UniProtVAR_040022V170MCHLE_HUMANDisease (BChE deficiency)527843566AV142M
18UniProtVAR_040023D198ECHLE_HUMANDisease (BChE deficiency)781368801AD170E
19UniProtVAR_040024S226GCHLE_HUMANDisease (BChE deficiency)370077923AS198G
20UniProtVAR_040025A227VCHLE_HUMANDisease (BChE deficiency)  ---AA199V
21UniProtVAR_040026A229TCHLE_HUMANDisease (BChE deficiency)  ---AA201T
22UniProtVAR_072098V232DCHLE_HUMANDisease (BChE deficiency)  ---AV204D
23UniProtVAR_040027T271MCHLE_HUMANDisease (BChE deficiency)28933389AT243M
24UniProtVAR_040028T278PCHLE_HUMANDisease (BChE deficiency)  ---AT250P
25UniProtVAR_040029E283DCHLE_HUMANPolymorphism16849700AE255D
26UniProtVAR_040030K295RCHLE_HUMANDisease (BChE deficiency)115624085AK267R
27UniProtVAR_072099V322MCHLE_HUMANPolymorphism754644618AV294M
28UniProtVAR_040031L335PCHLE_HUMANDisease (BChE deficiency)104893684AL307P
29UniProtVAR_040032A356DCHLE_HUMANDisease (BChE deficiency)770337031AA328D
30UniProtVAR_002362L358ICHLE_HUMANDisease (BChE deficiency)121918557AL330I
31UniProtVAR_072100G361CCHLE_HUMANDisease (BChE deficiency)  ---AG333C
32UniProtVAR_040033G393RCHLE_HUMANDisease (BChE deficiency)115129687AG365R
33UniProtVAR_040034R414CCHLE_HUMANDisease (BChE deficiency)745364489AR386C
34UniProtVAR_040035G418VCHLE_HUMANDisease (BChE deficiency)28933390AG390V
35UniProtVAR_040036F446SCHLE_HUMANDisease (BChE deficiency)  ---AF418S
36UniProtVAR_040037E488KCHLE_HUMANDisease (BChE deficiency)200998515AE460K
37UniProtVAR_072101R498WCHLE_HUMANPolymorphism115017300AR470W
38UniProtVAR_040038W499RCHLE_HUMANDisease (BChE deficiency)  ---AW471R
39UniProtVAR_040039F502LCHLE_HUMANDisease (BChE deficiency)769316835AF474L
40UniProtVAR_040040E525VCHLE_HUMANDisease (BChE deficiency)121918556AE497V
41UniProtVAR_040041R543CCHLE_HUMANDisease (BChE deficiency)199660374AR515C
42UniProtVAR_040042Q546LCHLE_HUMANDisease (BChE deficiency)  ---AQ518L

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (42, 42)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_072094K40RCHLE_HUMANPolymorphism116047990AK12R
02UniProtVAR_040012T52MCHLE_HUMANDisease (BChE deficiency)56309853AT24M
03UniProtVAR_040013F56ICHLE_HUMANDisease (BChE deficiency)531738678AF28I
04UniProtVAR_040014Y61CCHLE_HUMANDisease (BChE deficiency)116097205AY33C
05UniProtVAR_072730A62VCHLE_HUMANDisease (BChE deficiency)  ---AA34V
06UniProtVAR_040015P65SCHLE_HUMANDisease (BChE deficiency)148170012AP37S
07UniProtVAR_002360D98GCHLE_HUMANDisease (BChE deficiency)1799807AD70G
08UniProtVAR_040016D98HCHLE_HUMANDisease (BChE deficiency)  ---AD70H
09UniProtVAR_072095G103RCHLE_HUMANDisease (BChE deficiency)  ---AG75R
10UniProtVAR_072096E118DCHLE_HUMANDisease (BChE deficiency)  ---AE90D
11UniProtVAR_040017N124YCHLE_HUMANDisease (BChE deficiency)  ---AN96Y
12UniProtVAR_072097I127MCHLE_HUMANPolymorphism755600722AI99M
13UniProtVAR_040018P128SCHLE_HUMANDisease (BChE deficiency)3732880AP100S
14UniProtVAR_040019G143DCHLE_HUMANDisease (BChE deficiency)201820739AG115D
15UniProtVAR_040020L153FCHLE_HUMANDisease (BChE deficiency)747598704AL125F
16UniProtVAR_040021Y156CCHLE_HUMANDisease (BChE deficiency)121918558AY128C
17UniProtVAR_040022V170MCHLE_HUMANDisease (BChE deficiency)527843566AV142M
18UniProtVAR_040023D198ECHLE_HUMANDisease (BChE deficiency)781368801AD170E
19UniProtVAR_040024S226GCHLE_HUMANDisease (BChE deficiency)370077923AS198G
20UniProtVAR_040025A227VCHLE_HUMANDisease (BChE deficiency)  ---AA199V
21UniProtVAR_040026A229TCHLE_HUMANDisease (BChE deficiency)  ---AA201T
22UniProtVAR_072098V232DCHLE_HUMANDisease (BChE deficiency)  ---AV204D
23UniProtVAR_040027T271MCHLE_HUMANDisease (BChE deficiency)28933389AT243M
24UniProtVAR_040028T278PCHLE_HUMANDisease (BChE deficiency)  ---AT250P
25UniProtVAR_040029E283DCHLE_HUMANPolymorphism16849700AE255D
26UniProtVAR_040030K295RCHLE_HUMANDisease (BChE deficiency)115624085AK267R
27UniProtVAR_072099V322MCHLE_HUMANPolymorphism754644618AV294M
28UniProtVAR_040031L335PCHLE_HUMANDisease (BChE deficiency)104893684AL307P
29UniProtVAR_040032A356DCHLE_HUMANDisease (BChE deficiency)770337031AA328D
30UniProtVAR_002362L358ICHLE_HUMANDisease (BChE deficiency)121918557AL330I
31UniProtVAR_072100G361CCHLE_HUMANDisease (BChE deficiency)  ---AG333C
32UniProtVAR_040033G393RCHLE_HUMANDisease (BChE deficiency)115129687AG365R
33UniProtVAR_040034R414CCHLE_HUMANDisease (BChE deficiency)745364489AR386C
34UniProtVAR_040035G418VCHLE_HUMANDisease (BChE deficiency)28933390AG390V
35UniProtVAR_040036F446SCHLE_HUMANDisease (BChE deficiency)  ---AF418S
36UniProtVAR_040037E488KCHLE_HUMANDisease (BChE deficiency)200998515AE460K
37UniProtVAR_072101R498WCHLE_HUMANPolymorphism115017300AR470W
38UniProtVAR_040038W499RCHLE_HUMANDisease (BChE deficiency)  ---AW471R
39UniProtVAR_040039F502LCHLE_HUMANDisease (BChE deficiency)769316835AF474L
40UniProtVAR_040040E525VCHLE_HUMANDisease (BChE deficiency)121918556AE497V
41UniProtVAR_040041R543CCHLE_HUMANDisease (BChE deficiency)199660374AR515C
42UniProtVAR_040042Q546LCHLE_HUMANDisease (BChE deficiency)  ---AQ518L

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 2)

Asymmetric Unit (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1CARBOXYLESTERASE_B_2PS00941 Carboxylesterases type-B signature 2.CHLE_HUMAN118-128  1A:90-100
2CARBOXYLESTERASE_B_1PS00122 Carboxylesterases type-B serine active site.CHLE_HUMAN213-228  1A:185-200
Biological Unit 1 (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1CARBOXYLESTERASE_B_2PS00941 Carboxylesterases type-B signature 2.CHLE_HUMAN118-128  1A:90-100
2CARBOXYLESTERASE_B_1PS00122 Carboxylesterases type-B serine active site.CHLE_HUMAN213-228  1A:185-200

(-) Exons   (2, 2)

Asymmetric Unit (2, 2)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000002643811aENSE00001954521chr3:165555260-165555102159CHLE_HUMAN-00--
1.2ENST000002643812ENSE00000826111chr3:165548829-1655473051525CHLE_HUMAN1-5065061A:4-478 (gaps)475
1.4ENST000002643814ENSE00000780132chr3:165504099-165503933167CHLE_HUMAN506-562571A:478-52952
1.7cENST000002643817cENSE00001810445chr3:165491294-165490692603CHLE_HUMAN562-602410--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:524
 aligned with CHLE_HUMAN | P06276 from UniProtKB/Swiss-Prot  Length:602

    Alignment length:526
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551      
           CHLE_HUMAN    32 IIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV 557
               SCOP domains d4bdsa_ A: automated matches                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeee..eeee.eeeee..eeeeeeeeee.....hhhhh............eee......ee..........hhhhhh......ee....eeeeeee......eeeeeee...........hhhhhhhhhhhhhh.eeeee....hhhhhh..........hhhhhhhhhhhhhhhhhhhhh.eeeeeeeeeeehhhhhhhhhhhhhhhhhhhh.eeeee...........hhhhhhhhhhhhhhhh.....hhhhhhhhhhh.hhhhhhhhhhhh......................hhhhhhhh.......eeeeee...hhhhhh..............hhhhhhhhhhhhh...hhhhhhhhhhhhh...--...hhhhhhhhhhhhhhhhhhhhhhhhhhhhh....eeeeee.........hhhhh.....hhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhh....................eeeee......eee..hhhhhhhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) --------R-----------M---I----CV--S--------------------------------G----R--------------D-----Y--MS--------------D---------F--C-------------M---------------------------E---------------------------GV-T--D--------------------------------------M------P----D-----------R--------------------------M------------P--------------------D-I--C-------------------------------R--------------------C---V---------------------------S-----------------------------------------K---------WR--L----------------------V-----------------C--L----------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------H--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------CARBOXYLEST------------------------------------------------------------------------------------CARBOXYLESTERASE----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:4-478 (gaps) UniProt: 1-506 [INCOMPLETE]                                                                                                                                                                                                                                                                                                                                                                                                                                  --------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.4  PDB: A:478-529 UniProt: 506-562            Transcript 1 (2)
                 4bds A   4 IIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWV--QRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV 529
                                    13        23        33        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373   |  |383       393       403       413       423       433       443       453       463       473       483       493       503       513       523      
                                                                                                                                                                                                                                                                                                                                                                                                               377  |                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                  380                                                                                                                                                     

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 1)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 4BDS)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 4BDS)

(-) Gene Ontology  (28, 28)

Asymmetric Unit(hide GO term definitions)
Chain A   (CHLE_HUMAN | P06276)
molecular function
    GO:0003990    acetylcholinesterase activity    Catalysis of the reaction: acetylcholine + H2O = choline + acetate.
    GO:0001540    amyloid-beta binding    Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
    GO:0052689    carboxylic ester hydrolase activity    Catalysis of the hydrolysis of a carboxylic ester bond.
    GO:0003824    catalytic activity    Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
    GO:0033265    choline binding    Interacting selectively and non-covalently with choline, the amine 2-hydroxy-N,N,N-trimethylethanaminium.
    GO:0004104    cholinesterase activity    Catalysis of the reaction: an acylcholine + H2O = choline + a carboxylic acid anion.
    GO:0019899    enzyme binding    Interacting selectively and non-covalently with any enzyme.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0016788    hydrolase activity, acting on ester bonds    Catalysis of the hydrolysis of any ester bond.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
biological process
    GO:0019695    choline metabolic process    The chemical reactions and pathways involving choline (2-hydroxyethyltrimethylammonium), an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine.
    GO:0050783    cocaine metabolic process    The chemical reactions and pathways involving cocaine, an alkaloid obtained from the dried leaves of the shrub Erythroxylon coca. It is a cerebral stimulant and narcotic.
    GO:0007612    learning    Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience.
    GO:0008285    negative regulation of cell proliferation    Any process that stops, prevents or reduces the rate or extent of cell proliferation.
    GO:0050805    negative regulation of synaptic transmission    Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
    GO:0014016    neuroblast differentiation    The process in which a relatively unspecialized cell acquires specialized features of a neuroblast. There are at least four stages through which the pluripotent cells of epiblast or blastula become neuroblasts.
    GO:0043279    response to alkaloid    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0051593    response to folic acid    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus.
    GO:0051384    response to glucocorticoid    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
    GO:0007584    response to nutrient    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005641    nuclear envelope lumen    The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    CL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FPK  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FU4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    GOL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    THA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    UNX  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Ala A:101 - Pro A:102   [ RasMol ]  
 
Biological Unit
  Complete Structure
    Biological Unit 1  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  4bds
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  CHLE_HUMAN | P06276
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.1.1.8
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  177400
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  CHLE_HUMAN | P06276
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        CHLE_HUMAN | P062761eho 1ehq 1kcj 1p0i 1p0m 1p0p 1p0q 1xlu 1xlv 1xlw 2j4c 2pm8 2wid 2wif 2wig 2wij 2wik 2wil 2wsl 2xmb 2xmc 2xmd 2xmg 2xqf 2xqg 2xqi 2xqj 2xqk 2y1k 3djy 3dkk 3o9m 4aqd 4axb 4b0o 4b0p 4bbz 4tpk 4xii 5dyt 5dyw 5dyy 5k5e 5lkr

(-) Related Entries Specified in the PDB File

1eho MODEL OF (-)-COCAINE-BOUND BCHE COMPLEX.
1ehq MODEL OF (+)-COCAINE-BOUND BCHE COMPLEX
1kcj MODEL OF (-)-COCAINE-BOUND (-)-COCAINE HYDROLASE COMPLEX
1p0i CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE
1p0m CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE INCOMPLEX WITH A CHOLINE MOLECULE
1p0p CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE SUBSTRATE ANALOGBUTYRYLTHIOCHOLINE
1p0q CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE
1xlu X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO-FLUORIDATE ( DFP)INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING
1xlv ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINEDBY REACTION WITH ECHOTHIOPHATE
1xlw DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED)OBTAINED BY REACTION WITH ECHOTHIOPHATE
2j4c STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2
2wid AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1
2wif AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1
2wig NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4
2wij NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5
2wik NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6
2wil AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5
2wsl AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4
2xmb G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH SULFATE
2xmc G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH FLUORIDE ANION
2xmd G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ECHOTHIOPHATE
2xmg G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH VX
2xqf X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VX
2xqg X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VR
2xqi X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC CVX
2xqj X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE ENANTIOMER VX-(R)
2xqk X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE ENANTIOMER VX-(S)
2y1k STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT
4aqd CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE
4axb CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-PAM
4b0o CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH BENZYL PYRIDINIUM-4 -METHYLTRICHLOROACETIMIDATE
4b0p CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH METHYL 2-( PENTAFLUOROBENZYLOXYIMINO)PYRIDINIUM
4bbz STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (2-MIN SOAK): CRESYL-PHOSPHOSERINE ADDUCT